What's the difference between the three medications
Retatrutide has a long half-life (approximately 5-7 days), so skipping one dose wont meaningfully change the medications effects on alcohol metabolism
Results are not guaranteed and depend on many factors beyond medication alone
Mazdutides dual GLP-1/glucagon mechanism is structurally different from tirzepatides GLP-1/GIP combination, and its reported weight-loss figures (up to 16.65% at 60 weeks) sit closer to semaglutides range in its published trials to date, though its trial population and duration differ from the semaglutide and tirzepatide programs
When GLP-1 binds to its receptor, it amplifies the insulin signaling pathway, causing increased phosphorylation of insulin receptor substrates and activating the PI3K/Akt pathway, which ultimately results in enhanced glucose uptake, utilization within the liver, and reduced production of glucose (gluconeogenesis)
Predominantly, lipid ingestion causes GIP release